Evidence map›Paper›PMID 40497987›Full record

ReviewCells2025

Microbial Metabolite Effects on Vasculogenic Mimicry in Metastatic Cancers.

Mohammad Kamalabadi Farahani, Aisa Bahar, Hamed Tahmasebi, Valentyn Oksenych, Mojdeh Jahantigh

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mohammad Kamalabadi FarahaniTissue Engineering, Department of Tissue Engineering, School of Medicine, Shahroud University of Medical Sciences, Shahroud 36147-73943, Iran.ORCID 0000-0002-4768-2577
Aisa BaharSchool of Medicine, Shahroud University of Medical Sciences, Shahroud 36147-73943, Iran.
Hamed TahmasebiSchool of Medicine, Shahroud University of Medical Sciences, Shahroud 36147-73943, Iran.
Valentyn OksenychFaculty of Medicine, University of Bergen, 5020 Bergen, Norway.ORCID 0000-0002-5088-3791
Mojdeh JahantighCellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan 98167-43463, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggressive cancer cells can form new, functional blood vessel-like structures independently of endothelial cells, known as vasculogenic mimicry (VM), instead of the usual tumor blood vessel formation process. However, the symbiotic relationship between microbial communities and human cells ensures the upkeep of cellular metabolism and the functionality of the immune system and metastatic cancers. This interaction typically happens through the generation and management of hormonal intermediates, metabolites, secondary metabolites, proteins, and toxins. A disturbance in the balance between the host and microbiota can alter the dynamics of their relationship, creating a conducive environment for the development of diseases, such as cancers. This review aims to synthesize the initial evidence on the molecular processes governing the interactions between GM and cancer development and emphasize microbial metabolites' effects on vasculogenic mimicry. Some microbial metabolites could also contribute to developing interactions between microbes and the tumor microenvironment. While numerous obstacles persist, GM's immense significance and complete capability in shaping tailored anticancer plans cannot be exaggerated, highlighting the need to investigate a holistic method that includes microbial modulation therapy in cancer management.

Indexed as

MicrobiotaNeoplasmsNeovascularization, PathologicAnimalsHumansNeoplasm MetastasisTumor Microenvironmentgut microbiotametastatic cancersmicrobial metabolitevasculogenic mimicry

Identifiers

PMID40497987
PMCPMC12153797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.